SNDS: Strengths, Limitations and Perspectives for the Largest and Richest Real-World Database in EU
In this webinar, our experts provided an overview of the SNDS and the key working…
Jim Gallagher2020 年 10 月 20 日
Best Practices for Small to Mid-Size Companies to Advance Drug Discovery Programs
有能力根据研究需求进行扩展是成功的关键。Understanding when the…
Jim Gallagher2020 年 10 月 12 日
Intro to Smart In Silico Tools to Aid in Translating In Vitro & In Vivo Studies
Safety issues account for about a quarter of the attrition in drug projects, and can…
Jim Gallagher2020 年 10 月 5 日
